1. Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with asthma: results of a parallel-group study and a crossover study. Issue 1 (December 2015) Authors: O'Byrne, Paul; D'Urzo, Tony; Beck, Ekkehard; Fležar, Matjaž; Gahlemann, Martina; Hart, Lorna; Blahova, Zuzana; Toorawa, Robert; Beeh, Kai-Michael Journal: Respiratory research Issue: Volume 16:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and Safety of Iclepertin (BI 425809) in Patients With Schizophrenia: CONNEX, A Phase III Randomized Controlled Trial Program. (April 2023) Authors: Wunderlich, Glen; Blahova, Zuzana; Hake, Sanjay; Ikezawa, Satoru; Marder, Stephen; Falkai, Peter; Krystal, John H. Journal: CNS spectrums Issue: Volume 28:Number 2(2023) Page Start: 229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation of the efficacy and safety of orally administered BI425809 during a 12‐week treatment period compared with placebo in patients with cognitive impairment due to Alzheimer's disease: Human: Putative therapeutic results for Alzheimer's and related dementias. (7th December 2020) Authors: Wunderlich, Glen; Blahova, Zuzana; Garcia, Miguel; Huang, Songqiao; Pollentier, Stephane; Jessen, Frank Journal: Alzheimer's & dementia Issue: Volume 16(2020)Supplement 9 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial. Issue 1 (20th August 2018) Authors: Maher, Toby M; Stowasser, Susanne; Nishioka, Yasuhiko; White, Eric S; Cottin, Vincent; Noth, Imre; Selman, Moisés; Blahova, Zuzana; Wachtlin, Daniel; Diefenbach, Claudia; Jenkins, R Gisli Journal: BMJ open respiratory research Issue: Volume 5:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P1‐062: A PHASE II STUDY EVALUATING EFFICACY, SAFETY, AND TOLERABILITY OF ORAL BI 425809 IN PATIENTS WITH COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE DEMENTIA. (1st July 2019) Authors: Wunderlich, Glen; Jessen, Frank; Garcia, Miguel; Blahova, Zuzana Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7S(2019)Part 5 Page Start: P256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗